0
0
3/19/26 at 2:30pm
Organization
FDA.gov
Author
Office of the Commissioner
48 words
0
Comments
The U.S. Food and Drug Administration today approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection for weight loss and long-term maintenance of weight loss for certain adult patients.
You are the first to view
https://www.fda.gov/news-events/press-announcements/fda-approves-fourth-product-under-national-priority-voucher-program-higher-dose-semaglutide
Create an account
or login to join the discussion